Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson's Disease: An Open-Label, Pragmatic Trial.
about
Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson's Disease: An Open-Label, Pragmatic Trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@en
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@nl
type
label
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@en
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@nl
altLabel
Amantadine and the Risk of Dys ...... An Open-Label, Pragmatic Trial
@en
prefLabel
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@en
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@nl
P2093
P2860
P921
P356
P1433
P1476
Amantadine and the Risk of Dys ...... n Open-Label, Pragmatic Trial.
@en
P2093
Beomseok Jeon
Chae Won Shin
Hui-Jun Yang
Hyeyoung Park
Ji Young Yun
Mihee Jang
Woong-Woo Lee
P2860
P356
10.14802/JMD.18005
P407
P50
P577
2018-05-30T00:00:00Z